RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution

Table 1

Patients characteristics (𝑁=65).

Characteristic	Number	%
Sex
Male	29	55.4
Female	36	44.6
Age (years)
Mean	61.45 years
Range	30–85 years
FLIPI
Good	38	58.5
Intermediate	19	29.2
Poor	8	12.3
ECOG
1-2		96.9
Prior treatment
>2	26	4